Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellular Biomedicine Group Inc (NASDAQ:CBMG)

8.80
Delayed Data
As of 4:00pm ET
 +0.10 / +1.15%
Today’s Change
5.05
Today|||52-Week Range
15.45
-32.82%
Year-to-Date
No recent news for Cellular Biomedicine Group Inc.

Today’s Trading

Previous close8.70
Today’s open8.93
Day’s range8.80 - 8.93
Volume5,820
Average volume (3 months)52,221
Market cap$122.7M
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-22.94%
Earnings growth (this year)+16.75%
Earnings growth (next 5 years)--
Revenue growth (last year)-74.94%
P/E ratioNM
Price/Sales281.79
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
GNCAGenocea Biosciences ...-0.08-1.87%
EVGNEvogene Ltd+0.16+3.38%
AXSMAxsome Therapeutics ...0.000.00%
VSTMVerastem Inc+0.08+2.53%
Data as of 4:00pm ET, 08/16/2017

Financials

Last reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$627.9K
Annual profit (last year)-$28.2M
Net profit margin-4,492.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Director, Chief Executive &
Financial Officer
Bizuo Liu
Chief Operating Officer
Xia Meng
Corporate headquarters
Cupertino, California

Forecasts